GTx, Inc. (NASDAQ: GTXI) today announced that Robert J. Wills, Ph.D., has been appointed to the Company’s Board of Directors and will serve as GTx’s Executive Chairman as well as the Chairman of the Board’s Scientific and Development Committee, in each case effective March 2, 2015. Dr. Wills, who is retiring from Johnson & Johnson, brings to GTx over 35 years of pharmaceutical knowledge and operational experience, including preclinical and clinical research and development, business development and strategic partnering.
Help employers find you! Check out all the jobs and post your resume.
